Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024

Diabetes poses a significant public health challenge, particularly in Indonesia where 10.7 million people are affected, and this is predicted to increase to 13.7 million by 2030. Diabetes rates in Indonesia continue to rise and are predicted to affect younger age groups, highlighting the need to str...

Full description

Saved in:
Bibliographic Details
Main Authors: Kresnowati Lily, Suhartono Suhartono, Shaluhiyah Zahroh, Widjanarko Bagoes
Format: Article
Language:English
Published: EDP Sciences 2025-01-01
Series:E3S Web of Conferences
Online Access:https://www.e3s-conferences.org/articles/e3sconf/pdf/2025/05/e3sconf_icenis2024_02005.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832098536105181184
author Kresnowati Lily
Suhartono Suhartono
Shaluhiyah Zahroh
Widjanarko Bagoes
author_facet Kresnowati Lily
Suhartono Suhartono
Shaluhiyah Zahroh
Widjanarko Bagoes
author_sort Kresnowati Lily
collection DOAJ
description Diabetes poses a significant public health challenge, particularly in Indonesia where 10.7 million people are affected, and this is predicted to increase to 13.7 million by 2030. Diabetes rates in Indonesia continue to rise and are predicted to affect younger age groups, highlighting the need to strengthen preventive efforts, one of which is conducting earlier DM screening. This study examines the dropout rates in follow-up screenings for diabetes mellitus (DM) among members of Indonesia’s National Health Insurance (BPJS) from 2022 to June 2024. The research utilizes a descriptive method. The research variables are the number of BPJS membership, the percentage of Health screening, the percentage of DM risk from screening, the number of follow up, and the results of DM test. The analysis technique uses descriptive analysis. Nationally, the follow-up rate of screening increase from 1.81% in 2022 to 1.98% in 2023. Despite a slight recovery to 1.25% by mid-2024. The mean of follow-up rate nationally to 1.73%. These findings indicate the need for educational campaigns to raise awareness about the importance of DM screening and follow-up care. Further research is necessary to conduct a partial analysis related to community characteristics and factors influencing follow-up screening for DM.
format Article
id doaj-art-9ae2cfbc00b144b0bc23d8b0bef8b2f5
institution Kabale University
issn 2267-1242
language English
publishDate 2025-01-01
publisher EDP Sciences
record_format Article
series E3S Web of Conferences
spelling doaj-art-9ae2cfbc00b144b0bc23d8b0bef8b2f52025-02-05T10:49:10ZengEDP SciencesE3S Web of Conferences2267-12422025-01-016050200510.1051/e3sconf/202560502005e3sconf_icenis2024_02005Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024Kresnowati Lily0Suhartono Suhartono1Shaluhiyah Zahroh2Widjanarko Bagoes3Doctoral Program of Public Health, Faculty of Public Health, Universitas DiponegoroDepartment of Environmental Health, Faculty of Public Health, Universitas DiponegoroDepartment of Health Promotion, Faculty of Public Health, Universitas DiponegoroDoctoral Program of Public Health, Faculty of Public Health, Universitas DiponegoroDiabetes poses a significant public health challenge, particularly in Indonesia where 10.7 million people are affected, and this is predicted to increase to 13.7 million by 2030. Diabetes rates in Indonesia continue to rise and are predicted to affect younger age groups, highlighting the need to strengthen preventive efforts, one of which is conducting earlier DM screening. This study examines the dropout rates in follow-up screenings for diabetes mellitus (DM) among members of Indonesia’s National Health Insurance (BPJS) from 2022 to June 2024. The research utilizes a descriptive method. The research variables are the number of BPJS membership, the percentage of Health screening, the percentage of DM risk from screening, the number of follow up, and the results of DM test. The analysis technique uses descriptive analysis. Nationally, the follow-up rate of screening increase from 1.81% in 2022 to 1.98% in 2023. Despite a slight recovery to 1.25% by mid-2024. The mean of follow-up rate nationally to 1.73%. These findings indicate the need for educational campaigns to raise awareness about the importance of DM screening and follow-up care. Further research is necessary to conduct a partial analysis related to community characteristics and factors influencing follow-up screening for DM.https://www.e3s-conferences.org/articles/e3sconf/pdf/2025/05/e3sconf_icenis2024_02005.pdf
spellingShingle Kresnowati Lily
Suhartono Suhartono
Shaluhiyah Zahroh
Widjanarko Bagoes
Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024
E3S Web of Conferences
title Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024
title_full Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024
title_fullStr Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024
title_full_unstemmed Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024
title_short Drop-out to follow up screening of diabetes mellitus in Indonesia from national health insurance data 2022-2024
title_sort drop out to follow up screening of diabetes mellitus in indonesia from national health insurance data 2022 2024
url https://www.e3s-conferences.org/articles/e3sconf/pdf/2025/05/e3sconf_icenis2024_02005.pdf
work_keys_str_mv AT kresnowatilily dropouttofollowupscreeningofdiabetesmellitusinindonesiafromnationalhealthinsurancedata20222024
AT suhartonosuhartono dropouttofollowupscreeningofdiabetesmellitusinindonesiafromnationalhealthinsurancedata20222024
AT shaluhiyahzahroh dropouttofollowupscreeningofdiabetesmellitusinindonesiafromnationalhealthinsurancedata20222024
AT widjanarkobagoes dropouttofollowupscreeningofdiabetesmellitusinindonesiafromnationalhealthinsurancedata20222024